ARF6 and pancreatic neoplasm: In the present study, we describe a positive feedback loop about ERK1/2-ARF6 pathway that can inhibit the expression of DUSP6 in pancreatic cancer cells, which is equivalent to removeing the inhibition of ERK1/2 pathway.